Andreas Stallmach

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Collaborators (4)

Anne Klink

GERMANY

View details

Philipp A. Reuken

Jena University Hospital

GERMANY

View details

Fabian Sobotta

Eindhoven University of Technology

NETHERLANDS

View details

Axel Dignass

Goethe University Frankfurt

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andreas Stallmach

Research Interests

Explore related searches

Contact this professor

Articles (15)

Anti‐Inflammatory Potential of Beclometasone‐Loaded Filomicelles on Activated Human Monocytes

Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies

Correction to: Clinical and surgical factors for successful stoma reversal in patients with Crohn’s disease—results of a retrospective cohort study

Immunoadsorption to treat patients with severe post‐COVID syndrome

Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography

Variations and Predictors of Post-COVID Syndrome Severity in Patients Attending a Post-COVID Outpatient Clinic

Editorial: If STRIDE‐II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails—Authors' reply

Review article: Translating STRIDE‐II into clinical reality – Opportunities and challenges

Trends in the epidemiology of Clostridioides difficile infection in Germany

Mobile primary healthcare for post-COVID patients in rural areas: a proof-of-concept study

Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease

Letter: The importance of histological assessment—a further stride in STRIDE. Authors' reply

Chronisch-entzündliche Darmerkrankungen in der COVID-Pandemie: Manifestationen und Management

Correction to: Disease recurrence in patients with Crohn’s disease after biologic therapy or surgery: a meta-analysis

Letter: SARS‐CoV‐2‐induced gastrointestinal inflammation

Collaborators (4)

Anne Klink

Philipp A. Reuken

Fabian Sobotta

Axel Dignass

Make your next move.